Polymorphism in Pharmaceutical Solids. Marcel Dekker, New York, 1999.Brittain HG. Polymorphism in pharmaceutical solids. Drugs and the pharmaceutical sciences vol. 95. New York: Marcel Dekker; 1999.Morris, ’Polymorphism in pharmaceutical solids’ (Ed. J. Brittain), Marcel Dekker, New York 1999,...
16. Amorphous Solids
Vol.95, Polymorphism in pharmaceutical solids Hydration, polymorphism and disorder in organic solids, including materials of pharmaceutical relevanceThe studies described in this thesis are concerned with understanding and rationalising the inter-relationships between structural and other ... H Brittain - ...
Página 1 de 1Document31/12/2006http://www.netlibrary.com/nlreader/nlreader.dll?bookid=12783&filename=Cover.html
药物晶型最经典参考书 Polymorphism in Pharmaceutical Solids_Second Edition 晶体 资源共享 第6页 小木虫 论坛
polymorphism_pharmaceutical_solids_1999 热度: The Pharmaceutical Industry 热度: Brochure Moreinformationfromhttp://.researchandmarkets/reports/2179604/ Polymorphism.InthePharmaceuticalIndustry Description:Polymorphism–themultiplicityofstructuresorforms–isusedinmanydisciplines.Inchemistryitrefersto ...
当当中国进口图书旗舰店在线销售正版《【预订】Polymorphism in Pharmaceutical Solids, Second Edition 9781420073218》。最新《【预订】Polymorphism in Pharmaceutical Solids, Second Edition 9781420073218》简介、书评、试读、价格、图片等相关信息,尽在DangDang.com
polymorphism_pharmaceutical_solids_1999 热度: Salt Selection And Polymorphism In Pharmaceutical Industry 热度: One chemistry, two continents_ Function and maintenance of chemical polymorphism in the mint family (Lamiaceae) 热度: Polymorphism LectureObjectives ...
1.4 The Solid State in the Context of Pharmaceutical Development 7 1.4.1 Typical Drug Discovery and Development 7 1.4.2 The Solid State at the Interface of Drug Substance and Drug Product 10 1.4.3 Biopharmaceutics and Bioavailability of Solids 11 1.4.4 Pharmaceutical Quality Assessme...
10. Polymorphism in Pharmaceutical Solids, H.G. Brittain, Ed. (Marcel Dekker, Inc.: New York, 1999). 11. N. Rasenack and B.W. Müller, "Properties of Ibuprofen Crystallized Under Various Conditions: A Comparative Study," Drug Dev. Ind. Pharm. 28 (9) 1077–1089...